New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Heba Alshaker(University of East Anglia), Dmitri Pchejetski(University of East Anglia), Shyam Srivats, Qi Wang(Chengdu University of Traditional Chinese Medicine), Yimin Chao(University of East Anglia), Colin Cooper(Institute of Cancer Research)
Cited by 26
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
|Cancer Cell|2022|403
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174